Last reviewed · How we verify
Obsessive-compulsive disorder
Approved treatments
- Sertralin · Poznan University of Medical Sciences
- Prozac · RenJi Hospital
- Anafranil · Specgx Llc
- Luvox
Luvox works by blocking the reabsorption of serotonin in the brain, allowing more of this neurotransmitter to be available for communication between nerve cells. - Zoloft · Pfizer Inc.
Selective serotonin reuptake inhibitor (SSRI) that blocks the serotonin transporter, increasing synaptic serotonin to improve mood and reduce anxiety. - Prozac · Eli Lilly and Company
Fluoxetine inhibits CNS neuronal uptake of serotonin, though exact mechanism unknown.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Obsessive-compulsive disorder patent landscape — cliff calendar, originator estates, attackable patents
- Obsessive-compulsive disorder treatment landscape brief
- Obsessive-compulsive disorder treatment updates RSS
Frequently asked questions about Obsessive-compulsive disorder
What drugs treat Obsessive-compulsive disorder?
Tracked treatments include Sertralin, Prozac, Anafranil, Luvox, Zoloft.
What is the treatment for Obsessive-compulsive disorder?
Standard treatment for Obsessive-compulsive disorder includes Sertralin, Prozac, Anafranil, Luvox, Zoloft. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Obsessive-compulsive disorder patent cliff · Obsessive-compulsive disorder CI report
- Treatment: Sertralin · Poznan University of Medical Sciences
- Treatment: Prozac · RenJi Hospital
- Treatment: Anafranil · Specgx Llc
- Treatment: Luvox
- Treatment: Zoloft · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing